Western blot analyses of SS18-SSX, PRAME, and EZH2 showed PRAME expression in translocation positive SS (TP-SS) and in other STS cells, including the RD-ES Ewing sarcoma cell line, while the SW982 translocation negative (TN-SS) cells had no detectable expression. This evidence concerns the gene EZH2 and Ewing sarcoma.